Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2558.80 | 1445 / 1445 | 100% | 13.63 | 183 / 183 |
ovary | 100% | 3881.73 | 180 / 180 | 100% | 16.43 | 430 / 430 |
stomach | 100% | 3084.58 | 359 / 359 | 100% | 14.88 | 285 / 286 |
breast | 100% | 3118.24 | 459 / 459 | 100% | 20.30 | 1114 / 1118 |
intestine | 100% | 3311.46 | 966 / 966 | 100% | 16.16 | 525 / 527 |
lung | 100% | 2069.06 | 576 / 578 | 100% | 16.64 | 1154 / 1155 |
prostate | 100% | 2706.14 | 245 / 245 | 99% | 17.99 | 499 / 502 |
kidney | 100% | 2800.44 | 89 / 89 | 99% | 22.45 | 891 / 901 |
pancreas | 100% | 2807.23 | 328 / 328 | 99% | 15.57 | 176 / 178 |
thymus | 100% | 4064.40 | 653 / 653 | 99% | 27.87 | 598 / 605 |
bladder | 100% | 2951.71 | 21 / 21 | 99% | 14.51 | 497 / 504 |
brain | 98% | 1999.28 | 2589 / 2642 | 100% | 20.11 | 703 / 705 |
liver | 100% | 2396.32 | 226 / 226 | 97% | 16.34 | 395 / 406 |
uterus | 100% | 3289.80 | 170 / 170 | 97% | 13.22 | 444 / 459 |
adrenal gland | 100% | 2935.80 | 258 / 258 | 95% | 16.37 | 219 / 230 |
skin | 100% | 2584.97 | 1809 / 1809 | 95% | 10.92 | 448 / 472 |
adipose | 100% | 2819.63 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2979.64 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 2220.59 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 11.43 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.13 | 1 / 1 |
muscle | 100% | 3299.99 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 94% | 2317.42 | 811 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 10.62 | 74 / 80 |
lymph node | 0% | 0 | 0 / 0 | 90% | 8.18 | 26 / 29 |
peripheral blood | 74% | 691.59 | 684 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0140627 | Biological process | ubiquitin-dependent protein catabolic process via the C-end degron rule pathway |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0016604 | Cellular component | nuclear body |
GO_0005654 | Cellular component | nucleoplasm |
GO_0031462 | Cellular component | Cul2-RING ubiquitin ligase complex |
GO_0031965 | Cellular component | nuclear membrane |
GO_0005634 | Cellular component | nucleus |
GO_1990756 | Molecular function | ubiquitin-like ligase-substrate adaptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | KLHDC2 |
Protein name | Kelch domain containing 2 Kelch domain-containing protein 2 (Hepatocellular carcinoma-associated antigen 33) (Host cell factor homolog LCP) (Host cell factor-like protein 1) (HCLP-1) |
Synonyms | HCA33 |
Description | FUNCTION: Substrate-recognition component of a Cul2-RING (CRL2) E3 ubiquitin-protein ligase complex of the DesCEND (destruction via C-end degrons) pathway, which recognizes a C-degron located at the extreme C terminus of target proteins, leading to their ubiquitination and degradation . The C-degron recognized by the DesCEND pathway is usually a motif of less than ten residues and can be present in full-length proteins, truncated proteins or proteolytically cleaved forms . The CRL2(KLHDC2) complex specifically recognizes proteins with a diglycine (Gly-Gly) at the C-terminus, leading to their ubiquitination and degradation . The CRL2(KLHDC2) complex mediates ubiquitination and degradation of truncated SELENOK and SELENOS selenoproteins produced by failed UGA/Sec decoding, which end with a diglycine . The CRL2(KLHDC2) complex also recognizes proteolytically cleaved proteins ending with Gly-Gly, such as the N-terminal fragment of USP1, leading to their degradation . May also act as an indirect repressor of CREB3-mediated transcription by interfering with CREB3-DNA-binding . . |
Accessions | G3V2H2 ENST00000555739.5 [Q9Y2U9-2] ENST00000557247.1 Q9Y2U9 G3V3U8 ENST00000555443.5 [Q9Y2U9-2] ENST00000298307.10 [Q9Y2U9-1] ENST00000554589.5 |